Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Schering AG (SHR)
Financials 
Technical Analysis 0
BUY
Companies like Pfizer and Merck have been coming apart for quite awhile. Growth rate has gone from 30% to low single digits. When this happens, the P/E has to contract. There are more sellers than buyers. One of the few that is doing better is Schering AG. Growth rate is accelerating and have a good line up of drugs.
biotechnologypharmaceutical
Showing 1 to 1 of 1 entries
- «
- ‹
- 1
- ›
- »
Schering AG (SHR) Frequently Asked Questions
What is Schering AG stock symbol?
Schering AG is a OTC stock, trading under the symbol SHR (previously SHR-N on Stockchase) on the undefined (undefined). It is usually referred to as or SHR
Is Schering AG a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on SHR (previously SHR-N on Stockchase) on Stockchase. Read the latest expert commentary for Schering AG.
Is Schering AG a good investment or a top pick?
Schering AG was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Schering AG.
Why is Schering AG stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Schering AG.
Is Schering AG worth watching?
Schering AG is covered by Stockchase experts and is worth watching.
